Evidence map›Paper›PMID 9722633›Full record

ArticleNucleic acids research1998

Mapping of interaction domains between human repair proteins ERCC1 and XPF.

W L de Laat, A M Sijbers, H Odijk, N G Jaspers, J H Hoeijmakers

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mechanism of action of nucleotide excision repair machinery.Biochemical Society transactions · 2022
    Review
  10. Review
  11. Article
  12. Clinical Perspectives of ERCC1 in Bladder Cancer.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Spectrin and its interacting partners in nuclear structure and function.Experimental biology and medicine (Maywood, N.J.) · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

W L de LaatDepartment of Cell Biology and Genetics, Medical Genetics Centre, Erasmus University, PO Box 1738,3000 DR Rotterdam, The Netherlands.
A M Sijbers
H Odijk
N G Jaspers
J H Hoeijmakers
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ERCC1-XPF is a heterodimeric protein complexinvolved in nucleotide excision repair and recombinational processes. Like its homologous complex in Saccharomyces cerevisiae , Rad10-Rad1, it acts as a structure-specific DNA endonuclease, cleaving at duplex-single-stranded DNA junctions. In repair, ERCC1-XPF and Rad10-Rad1 make an incision on the the 5'-side of the lesion. No humans with a defect in the ERCC1 subunit of this protein complex have been identified and ERCC1-deficient mice suffer from severe developmental problems and signs of premature aging on top of a repair-deficient phenotype. Xeroderma pigmentosum group F patients carry mutations in the XPF subunit and generally show the clinical symptoms of mild DNA repair deficiency. All XP-F patients examined demonstrate reduced levels of XPF and ERCC1 protein, suggesting that proper complex formation is required for stability of the two proteins. To better understand the molecular and clinical consequences of mutations in the ERCC1-XPF complex, we decided to map the interaction domains between the two subunits. The XPF-binding domain comprises C-terminal residues 224-297 of ERCC1. Intriguingly, this domain resides outside the region of homology with its yeast Rad10 counterpart. The ERCC1-binding domain in XPF maps to C-terminal residues 814-905. ERCC1-XPF complex formation is established by a direct interaction between these two binding domains. A mutation from an XP-F patient that alters the ERCC1-binding domain in XPF indeed affects complex formation with ERCC1.

Indexed as

DNA RepairSaccharomyces cerevisiae ProteinsAnimalsDNA-Binding ProteinsDNA Repair EnzymesEndonucleasesFungal ProteinsHumansMacromolecular SubstancesMammalsMiceMice, KnockoutPolymerase Chain ReactionProtein BiosynthesisProteinsSequence DeletionDNA-Binding ProteinsDNA Repair EnzymesEndonucleasesERCC1 protein, humanErcc1 protein, mouseFungal ProteinsMacromolecular SubstancesProteinsRAD10 protein, S cerevisiaeRAD1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSingle-Strand Specific DNA and RNA Endonucleasesxeroderma pigmentosum group F protein

Identifiers

PMID9722633
PMCPMC147836
OpenAlexW2132438813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.